Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now later-stage tilt small index

Tachycardia: later-stage trial registry

1 of 9 indexed Tachycardia trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #1,916 of 28,707 conditions by registered trial count.

9 US clinical trials · 1 currently recruiting · #1,916 of 28,707 conditions by registered trial count

Tachycardia: 9 US clinical trials tracked, 1 recruiting.

Tachycardia is the subject of 9 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Satish R. Raj, running 2 of these trials.

Enrollment posture brief

Registry condition tachycardia

OPEN 1 | RECR 11% | LATE 2 | EARLY 1 | RANK #1916 | SPON 2

Nearest open-share peer: Alcohol Use Disorders (11% recruiting · 9 trials)

Acute Lymphoblastic Leukemia55.6%Acute Respiratory Distress S55.6%Acute Otitis Media22.2%Acute Heart Failure11.1%Tachycardia (this)11%
Open-enrollment share among volume-matched conditions near Tachycardia

Tachycardia lists 1 open slots (11% of 9 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Tachycardia on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Tachycardia is recruiting below its size-band peers.

    1 of 9 indexed trials (11.1%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Tachycardia research.

    Satish R. Raj accounts for 2 of 9 trials (22.2%). 7 distinct sponsors appear on at least one study for this condition label.

  3. Typical Tachycardia enrolment sits around 462 participants.

    Median target enrolment is 462 among the 9 trials that report a genuine target (sentinel values excluded). 0 of those (0%) plan for fewer than 100 participants.

  4. Tachycardia splits between interventional and observational designs.

    6 interventional and 3 observational studies make up this index (66.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 11Phase 42

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 4 2

Top Sponsors

Named interventions

Most-linked intervention names on Tachycardia records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Cardiac resynchronization therapy with defibrillation Device
1 trials
Ovatio DR 6550 Device
1 trials
Ovatio DR 6550 Device
1 trials
Medtronic Implantable Cardioverter Defibrillator Device
1 trials
VITALITY 2 Implantable Cardioverter Defibrillator Device
1 trials
cardiac implantable electronic devices (CIEDs) Device
1 trials
Intrinsic Heart Rate Drug
1 trials
QSweat Procedure
1 trials

US sites by state

Facility locations filed on Tachycardia trials. A trial with sites in several states counts in each.

Georgia 3 trials
Tennessee 2 trials
South Carolina 2 trials
Pennsylvania 2 trials
Maryland 2 trials
Louisiana 2 trials
Florida 2 trials
California 2 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Tachycardia page

9 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 Tachycardia trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Satish R. Raj sponsors the most Tachycardia trials on record, review their full trial history before evaluating a specific study. See Satish R. Raj's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Tachycardia condition card totals 9 registered trials; most-linked intervention Cardiac resynchronization therapy with defibrillation; top US site state Georgia. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.